Skip to content

Clinical trials

Epilepsy trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Country / region: Serbia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20084
20091
20101
20112
20121
20132
20142
20152
20191
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5
Eisai Inc.3
Longboard Pharmaceuticals3
Eisai Limited2
Sumitomo Pharma America, Inc.2
UCB BIOSCIENCES, Inc.2
UCB Pharma2
Bial - Portela C S.A.1
Institut za Rehabilitaciju Sokobanjska Beograd1
UCB Biopharma SRL1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy22
Seizures10
Neurodevelopmental Disorders3
Epilepsies, Myoclonic2
Lennox Gastaut Syndrome2
Drug Resistant Epilepsy1
Epilepsies, Partial1
Seizures, Febrile1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.